Samir Mitragotri
- Pharmaceutical Science top 0.01%
- Advancements in Transdermal Drug Delivery 113
- Advanced Drug Delivery Systems 45
- Biomaterials top 0.01%
- Nanoparticle-Based Drug Delivery 71
- Biomedical Engineering top 0.01%
- Nanoplatforms for cancer theranostics 20
- Dermatology top 0.05%
- Dermatology and Skin Diseases 33
- Surfaces, Coatings and Films top 0.1%
-
- RNA Interference and Gene Delivery 52
- Lipid Membrane Structure and Behavior 23
-
- Immunotherapy and Immune Responses 26
- Co-authors
- Aaron C. AnselmoJulie A. ChampionRóbert LangerJoerg LahannJin‐Wook YooZongmin ZhaoSutapa BaruaNishit Doshi
- Journals
- Journal of Controlled Release (56 papers)Bioengineering & Translational Medicine (37 papers)Pharmaceutical Research (21 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Samir Mitragotri
352 papers receiving 47.7k citations
Hit Papers
Peers
Comparison fields: 5 of 198
- Pharmaceutical Science 12.2k
- Biomaterials 13.5k
- Biomedical Engineering 16.6k
- Dermatology 3.2k
- Surfaces, Coatings and Films 2.3k
Countries citing papers authored by Samir Mitragotri
This map shows the geographic impact of Samir Mitragotri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Mitragotri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Mitragotri more than expected).
Fields of papers citing papers by Samir Mitragotri
This network shows the impact of papers produced by Samir Mitragotri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Mitragotri. The network helps show where Samir Mitragotri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Samir Mitragotri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 39 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 8 | |
| 9 | 2024 | 10 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 68 | |
| 13 | 2021 | 27 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 4 | |
| 16 | 2020 | 6 | |
| 17 | 2020 | 81 | |
| 18 | 2020 | 39 | |
| 19 | 2018 | 288 | |
| 20 | Role of target geometry in phagocytosisbreakdown → | 2006 | 1634 |
About Samir Mitragotri
Samir Mitragotri is a scholar working on Pharmaceutical Science, Dermatology and Biomaterials, having authored 357 papers that have together received 48.6k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (113 papers), Nanoparticle-Based Drug Delivery (71 papers), RNA Interference and Gene Delivery (52 papers), Advanced Drug Delivery Systems (45 papers), Dermatology and Skin Diseases (33 papers), Immunotherapy and Immune Responses (26 papers), Lipid Membrane Structure and Behavior (23 papers) and Nanoplatforms for cancer theranostics (20 papers). The work is most often cited by research in Pharmaceutical Science (12.2k citations), Biomaterials (13.5k citations) and Biomedical Engineering (16.6k citations). Samir Mitragotri has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Aaron C. Anselmo, Julie A. Champion, Róbert Langer, Joerg Lahann, Jin‐Wook Yoo, Zongmin Zhao, Sutapa Barua, Nishit Doshi, Yogesh K. Katare and Mark R. Prausnitz. Their work appears in journals such as Journal of Controlled Release, Bioengineering & Translational Medicine, Pharmaceutical Research, Proceedings of the National Academy of Sciences and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.